Proto Labs Inc

Listed Company

PRLBCIK 0001443669NYSELarge AcceleratedFabricated Structural Metal ProductsMinnesotaFY ends Dec 31

Period

FY 2025

Revenue

—

Net Income

$21.24M

Total Assets

$763.41M

Equity

$673.93M

Shares Out

23.79M

Op. Cash Flow

$74.50M

PRLB$77.59+93.35% · past yearDBEQ Basic

Daily closing prices

Business

Proto Labs is a digital manufacturing service provider enabling companies to streamline production of custom parts across the entire product lifecycle, from prototyping through end-use production. The company offers injection molding, CNC machining, 3D printing, and sheet metal fabrication through a hybrid model combining owned manufacturing factories and a global network of manufacturing partners. Proto Labs serves a large customer base including many Fortune 100 companies across diverse industries via proprietary quoting and manufacturing software accessible through web-based interfaces, with operations in the United States and Europe.

Summary from 10-K filed 2026-02-20

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	533	501	504	488	488
Cost of revenue	296	278	282	273	265
Gross profit	237	223	222	215	223
Marketing and sales	98	92	88	83	82
Research and development	43	41	40	38	44
General and administrative	70	64	66	68	56
Restructuring and transformation costs	749,000	0	0	—	—
Costs related to disposal and exit activities	342,000	6	215,000	—	—
Total operating expenses	212	203	194	313	182
Income from operations	25	20	28	−98	40
Other income (expense), net	6	5	−215,000	106,000	−158,000
Income before income taxes	31	25	28	−98	40
Provision for income taxes	10	8	11	6	7
Net income	21	17	17	−103	33
Basic (in dollars per share)	0.89	0.66	0.66	−3.77	1.21
Diluted (in dollars per share)	0.88	0.66	0.66	−3.77	1.21
Basic (in shares)	24	25	26	27	28
Diluted (in shares)	24	25	26	27	28
Foreign currency translation adjustments	7	−228,000	5	—	—
Net unrealized gains on investments in securities	195,000	257,000	977,000	−1	−119,000
Comprehensive income	28	17	24	−121	20

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	111	89	84	57	66
Short-term marketable securities	17	14	19	24	12
Accounts receivable, net of allowance for credit losses of $2,668 and $1,975 as of December 31, 2025 and December 31, 2024, respectively	79	67	73	76	80
Inventory	14	12	14	14	13
Prepaid expenses and other current assets	10	10	9	13	11
Income taxes receivable	2	3	2	4	1
Total current assets	234	195	201	187	183
Property and equipment, net	215	227	254	258	280
Goodwill	274	274	274	274	401
Other intangible assets, net	19	21	26	31	38
Long-term marketable securities	14	18	8	26	14
Operating lease assets	3	3	5	4	6
Finance lease assets	424,000	692,000	960,000	18	2
Other long-term assets	4	5	5	5	4
Total assets	763	744	772	802	929
Accounts payable	15	16	16	17	25
Accrued compensation	24	17	15	13	14
Accrued liabilities and other	27	20	17	22	12
Current operating lease liabilities	1	1	2	2	3
Current finance lease liabilities	286,000	309,000	296,000	18	550,000
Total current liabilities	67	53	50	72	55
Long-term operating lease liabilities	2	2	3	2	2
Long-term finance lease liabilities	0	287,000	595,000	0	1
Long-term deferred tax liabilities	17	14	19	26	36
Other long-term liabilities	4	5	5	4	6
Total liabilities	89	73	77	105	100
Preferred stock, $0.001 par value, authorized 10,000,000 shares; issued and outstanding 0 shares as of December 31, 2025 and December 31, 2024, respectively	0	0	0	0	0
Common stock, $0.001 par value, authorized 150,000,000 shares; issued and outstanding 23,627,422 and 24,226,088 shares as of December 31, 2025 and December 31, 2024, respectively	24,000	24,000	26,000	27,000	28,000
Additional paid-in capital	454	454	467	474	469
Retained earnings	241	244	256	258	377
Accumulated other comprehensive loss	−21	−28	−28	−34	−17
Total shareholders' equity	674	670	695	698	828
Total liabilities and shareholders' equity	763	744	772	802	929

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	34	36	38	39	40
Stock-based compensation expense	16	17	16	18	19
Deferred taxes	3	−5	−8	−9	339,000
Interest on finance lease obligations	20,000	33,000	1	0	0
Loss on foreign currency translation	0	0	4	0	0
Loss on impairment of equipment	0	256,000	0	0	—
Impairments related to exit and closure of Germany business	448,000	2	0	3	0
Gain on disposal of property and equipment	−4,000	−13,000	−498,000	−1	0
Other	−223,000	1,000	154,000	35,000	842,000
Accounts receivable	−12	10	3	2	−20
Inventories	−2	1	112,000	−310,000	−2
Prepaid expenses and other	1	−560,000	4	−2	64,000
Income taxes	508,000	−691,000	2	−3	−774,000
Accounts payable	−333,000	480,000	−2	1	5
Accrued liabilities and other	14	835,000	−1	461,000	−7
Net cash provided by operating activities	75	78	73	62	55
Purchases of property, equipment and other capital assets	−15	−9	−28	−22	−34
Proceeds from sales of property, equipment and other capital assets	834,000	34,000	699,000	4	0
Purchases of other assets and investments	0	0	−1	0	0
Purchases of marketable securities	−17	−25	0	−47	−16
Proceeds from sales of marketable securities	0	1	0	2	65
Proceeds from maturities of marketable securities	18	19	24	19	18
Net cash used in investing activities	−13	−14	−5	−43	−95
Proceeds from issuance of common stock from equity plans	6	4	4	4	6
Purchases of shares withheld for tax obligations	−3	−2	−1	−2	−4
Repurchases of common stock and other	−43	−60	−44	−30	−23
Principal repayments of finance lease obligations	−309,000	−296,000	−306,000	−531,000	−552,000
Net cash used in financing activities	−40	−59	−42	−28	−22
Effect of exchange rate changes on cash and cash equivalents	1	−418,000	368,000	−436,000	−54,000
Net increase (decrease) in cash and cash equivalents	22	5	27	−9	−62
Cash paid for interest	58,000	136,000	1	101,000	28,000
Cash paid for taxes	7	14	16	19	8

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is Proto Labs Inc's CIK number?

Proto Labs Inc's SEC CIK number is 0001443669 (1443669). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find Proto Labs Inc's SEC filings?

All of Proto Labs Inc's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did Proto Labs Inc last report earnings?

Proto Labs Inc (PRLB) most recently filed an earnings 8-K with the SEC on May 1, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001443669-26-000023). This is Proto Labs Inc's most recent earnings filing of record — not a forecast of its next earnings date.

What is Proto Labs Inc's most recent earnings 8-K?

Proto Labs Inc's latest earnings 8-K (Item 2.02) was filed May 1, 2026 under accession 0001443669-26-000023. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View Proto Labs Inc's latest earnings 8-K →
Look up any company's CIK number →